News

Novo Nordisk stock crashes after company cuts sales, profit outlook on weight-loss drug competition

Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...
Fierce Pharma1d

Novo Nordisk names new CEO as the obesity drugmaker cuts sales, profit outlook

Novo Nordisk has named Maziar Mike Doustdar, currently the company’s EVP of international operations, as the new CEO. Doustdar will succeed Lars Fruergaard Jørgensen, whose surprise abdication was ...

Novo Nordisk shares fall 20% after company names new CEO and lowers its financial outlook

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

Novo Nordisk Stock Drops Further on Bank of America Downgrade

U.S.-listed shares of Novo Nordisk fell sharply for a second straight day Wednesday, this time after Bank of America ...

Novo CEO’s First Test is Winning Back the US Weight Loss Market

Novo Nordisk A/S’s best-sellers Ozempic and Wegovy transformed the firm into a global pharmaceutical giant. But four years ...
InvestorsHub on MSN1d

Novo Nordisk appoints Mike Doustdar as new CEO; Chief Scientific Officer to retire

Novo Nordisk (NYSE:NVO) announced on Tuesday that Maziar Mike Doustdar will become its new president and chief executive ...

Ozempic maker Novo Nordisk has its worst day since Black Monday

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
TMCnet8h

Novo Nordisk A/S (NVO) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith continues its investigation on behalf of Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO) investors concerning the Company's possible violations of federal ...